Active ingredientFlurazepamCat. No. P-F099-001CAS 17617-23-1Family · Pharmaceutical analytical standards
Flurazepam
A long-acting hypnotic benzodiazepine, patented and introduced into medicine in 1968, among the first benzodiazepine hypnotics on the market: it is indicated for the short-term treatment of insomnia. This family brings together the active ingredient, pharmacopoeial impurities, nitrosamines and other impurities.
Did you know?The drug itself has a half-life of about 2 hours, but its active metabolite, N-desalkylflurazepam, has a half-life of 47-100 hours and stays in the blood for days.
Go to the active ingredient →Active ingredientFlurazepamCat. No. P-F099-001CAS 17617-23-1
Active ingredientFlurazepam DihydrochlorideCat. No. P-F099-002CAS 1172-18-5
Pharmacopoeial impurityFlurazepam EP Impurity ACat. No. P-F099-003CAS 36105-18-7
NitrosamineN-Nitroso Flurazepam Desethyl ImpurityCat. No. P-F099-005
ImpurityFlurazepam Impurity 1Cat. No. P-F099-006CAS 97716-04-6
Impurity2-HydroxyethylflurazepamCat. No. P-F099-007CAS 20971-53-3
ImpurityFlurazepam Desethyl ImpurityCat. No. P-F099-008CAS 17656-74-5
ImpurityFlurazepam Impurity 2Cat. No. P-F099-009
Active ingredientFlurazepam MonohydrochlorideCat. No. P-F099-010CAS 36105-20-1
ImpurityFlurazepam N-OxideCat. No. P-F099-012CAS 53514-87-7
ImpurityFlurazepam Quinolone AnalogCat. No. P-F099-013CAS 100234-75-1
ImpurityN-Desethyl Flurazepam HydrochlorideCat. No. P-F099-014CAS 19011-75-7No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.